Chemically inducible antisense oligonucleotides for cell-specific gene silencing

Area of Science:

• Biochemistry
• Molecular Biology
• Therapeutic Development

Background:

• Antisense oligonucleotides (ASOs) offer precise gene silencing for therapeutic applications.
• Achieving cell-specific ASO function is crucial to minimize off-target effects and enhance safety.

Purpose of the Study:

• To develop a novel class of chemically inducible ASOs (iASOs) for tumor-cell-selective gene silencing.
• To establish a platform for conditional gene regulation using H2O2-triggered activation.

Main Methods:

• Post-synthetic incorporation of phenylboronic acid (BO) caging groups into ASO backbones.
• Development of iASOs activated by hydrogen peroxide (H2O2)-triggered removal of BO groups.
• Utilizing an EGFP reporter system and targeting the endogenous Bcl2 gene to assess knockdown efficiency and cell death induction.

Main Results:

• Optimal BO-modified iASOs showed minimal gene silencing in normal cells but achieved >80% knockdown in tumor cells.
• Demonstrated successful targeting of the Bcl2 gene, leading to controlled gene silencing and induced cell death.
• Established a simple and effective platform for conditional gene regulation.

Conclusions:

• Developed a novel class of chemically inducible ASOs (iASOs) for targeted gene therapy.
• H2O2-triggered activation of BO-caged ASOs enables tumor-cell-selective gene silencing.
• This platform facilitates the development of safer and more effective cell-specific ASO therapeutics.